AwardedPRTGoods€470,250
IMUNOMODULADORES - PEMBROLIZUMAB - 2 MESES
- Published
- Published 7 May 2026
Overview
Serviços de Saúde da Região Autónoma da Madeira procured immunomodulator pembrolizumab for a two-month supply period. The contract, valued at €470,250, was awarded to Merck Sharp & Dohme, LDA (MSD) on 29 April 2026.
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €470,250
- Procedure
- Selective
- Published
- 7 May 2026
Pharmaceutical productsVarious medicinal products
Award outcome
- Awarded value
- €470,250
- Award date
- 29 April 2026
- Contract period
- — → 28 June 2026
- MERCK SHARP & DOHME,LDA -MSD
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
7 May 2026
Contracting authority
Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
Procuring entityFunchal, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.